BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9351465)

  • 1. [New therapeutic principle in the management of cardiac insufficiency: A II antagonists. Results of the ELITE study (Evaluation of Losartan In The Elderly)].
    Dtsch Med Wochenschr; 1997 Sep; 122(39 Suppl):1-4. PubMed ID: 9351465
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of angiotensin II-antagonists].
    Internist (Berl); 1998 Sep; 39(9 Suppl Zum Stelle):1-4. PubMed ID: 9772714
    [No Abstract]   [Full Text] [Related]  

  • 3. [AT1 angiotensin receptor inhibition as a new therapeutic possibility].
    Hunyady L; Nagy L
    Orv Hetil; 1997 Oct; 138(41):2583-90. PubMed ID: 9411327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
    McMurray JJ
    J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):89-92. PubMed ID: 11881104
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
    Costantino S; Millozzi F; Scarlata S
    Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
    Konstam MA; Neaton JD; Poole-Wilson PA; Pitt B; Segal R; Sharma D; Dasbach EJ; Carides GW; Dickstein K; Riegger G; Camm AJ; Martinez FA; Bradstreet DC; Ikeda LS; Santoro EP;
    Am Heart J; 2005 Jul; 150(1):123-31. PubMed ID: 16084158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Losartan--a nonpeptide antagonist of angiotensin-II receptors in the treatment of heart failure].
    Berezin AE; Fushteĭ IM
    Klin Med (Mosk); 1998; 76(7):12-5. PubMed ID: 9742770
    [No Abstract]   [Full Text] [Related]  

  • 8. [Angiotensin-II-antagonism: new hope for the management of cardiac insufficiency].
    Z Kardiol; 1997 Sep; 86(9 Suppl Angio):1-4. PubMed ID: 9373391
    [No Abstract]   [Full Text] [Related]  

  • 9. [The outlook for the use of the nonpeptide angiotensin II-receptor antagonist losartan in treating heart failure].
    Dunaev VV; Berezin AE
    Eksp Klin Farmakol; 1999; 62(4):77-80. PubMed ID: 10513345
    [No Abstract]   [Full Text] [Related]  

  • 10. [ELITE II. AT1-blockers not better, but more tolerable than ACE-inhibitors].
    Berger D
    Internist (Berl); 2000 Jan; 41(1):A37. PubMed ID: 10712087
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of losartan and captopril in ELITE II.
    Meyer FP
    Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022947
    [No Abstract]   [Full Text] [Related]  

  • 12. Are angiotensin II receptor antagonists indicated in chronic heart failure?
    Komajda M
    Heart Fail Monit; 2002; 2(3):85-7. PubMed ID: 12634889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
    Leary AC; MacDonald TM
    Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiotensin II antagonists: a promising pathway].
    Cohen-Solal A
    Arch Mal Coeur Vaiss; 2000 Jun; Spec No():10-1, 15. PubMed ID: 10949700
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of losartan and captopril in ELITE II.
    Hall A
    Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022946
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of Losartan in the Elderly (ELITE) Trial: clinical implications.
    Pitt B
    Eur Heart J; 1997 Aug; 18(8):1197-9. PubMed ID: 9458406
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current therapy: losartan].
    Degaute JP; Sternon J
    Rev Med Brux; 1997 Oct; 18(5):335-8. PubMed ID: 9441330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
    Karlsen FM; Kamper AL
    Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of losartan and captopril on QT dispersion in elderly patients with heart failure. ELITE study group.
    Brooksby P; Robinson PJ; Segal R; Klinger G; Pitt B; Cowley AJ
    Lancet; 1999 Jul; 354(9176):395-6. PubMed ID: 10437875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.